Ronald Wihal Oei
Ronald Wihal Oei has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Fangfang Kong
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China
5 shared publications- Hongmei Ying
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
5 shared publications - Chaosu Hu
Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China
4 shared publications Chunying Shen
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, People's Republic of China,
4 shared publicationsLin Kong
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China,
4 shared publicationsLulu Ye
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, People's Republic of China,
4 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Validity of the Health Index for Healthcare Utilization in Brunei Darussalam: Cross-Sectional Study (Preprint)
BACKGROUND Noncommunicable diseases (NCDs) are the leading cause of death globally, and much of this burden is driven by modifiable lifestyle factors, highlighting the need for effective prevention strategies. Composite digital health scores could support population-level risk stratification, but their measurement properties are rarely evaluated against routinely collected health records. OBJECTIVE This study assessed the validity and reliability of a proposed “Health Index” among 5,997 users, delivered through BruHealth, the national mobile health app of Brunei Darussalam. METHODS In this cross-sectional study, we analyzed Health Index data from BruHealth users who were 18 years old and above. Individuals who are pregnant are excluded. We assessed the concurrent-criterion validity by correlating the Health Index score with the number of outpatient visits during the period of one year preceding completion of the Health Index. For construct validity, we compared Health Index scores among three groups of users with different health statuses (clinical conditions). For the reliability, we analyzed test-retest intraclass correlation (ICC Type 2) from their repeated submission of Health Index. RESULTS The Health Index score was negatively correlated with number of visits related to NCDs during the recent one-year period (Spearman ρ=−0.23, P<.001). Mean number of visits was also significantly different across Health Index risk groups (healthy n=1,871, at risk n=4,102, poor health n=24; P<.001). The mean Health Index scores were strongly significantly different among the three groups by health status or clinical conditions (P<.001). For the repeated submission of Health Index, the test-retest ICC was 0.636 (95% CI: 0.59, 0.68) which suggest moderate reliability. CONCLUSIONS Health Index, which has been integrated into the Brunei national mobile health application, showed moderate test-retest reliability and evidence of concurrent-criterion validity in measuring overall health status and stratifying people into different risk groups.
- 22 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessValidity of the Health Index for Healthcare Utilization in Brunei Darussalam: Cross-Sectional Study (Preprint)
BACKGROUND Noncommunicable diseases (NCDs) are the leading cause of death globally, and much of this burden is driven by modifiable lifestyle factors, highlighting the need for effective prevention strategies. Composite digital health scores could support population-level risk stratification, but their measurement properties are rarely evaluated against routinely collected health records. OBJECTIVE This study assessed the validity and reliability of a proposed “Health Index” among 5,997 users, delivered through BruHealth, the national mobile health app of Brunei Darussalam. METHODS In this cross-sectional study, we analyzed Health Index data from BruHealth users who were 18 years old and above. Individuals who are pregnant are excluded. We assessed the concurrent-criterion validity by correlating the Health Index score with the number of outpatient visits during the period of one year preceding completion of the Health Index. For construct validity, we compared Health Index scores among three groups of users with different health statuses (clinical conditions). For the reliability, we analyzed test-retest intraclass correlation (ICC Type 2) from their repeated submission of Health Index. RESULTS The Health Index score was negatively correlated with number of visits related to NCDs during the recent one-year period (Spearman ρ=−0.23, P<.001). Mean number of visits was also significantly different across Health Index risk groups (healthy n=1,871, at risk n=4,102, poor health n=24; P<.001). The mean Health Index scores were strongly significantly different among the three groups by health status or clinical conditions (P<.001). For the repeated submission of Health Index, the test-retest ICC was 0.636 (95% CI: 0.59, 0.68) which suggest moderate reliability. CONCLUSIONS Health Index, which has been integrated into the Brunei national mobile health application, showed moderate test-retest reliability and evidence of concurrent-criterion validity in measuring overall health status and stratifying people into different risk groups.
- Open Access
- 26 January 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10 (1) , e74101
An Innovative Population Health Tool for Overall Health Status Assessment: Prospective Observational Study
Background: The World Health Organization reported that noncommunicable diseases (NCDs) contribute to around 74% of deaths worldwide. A similar phenomenon can also be observed in Brunei Darussalam. One of the most cost-effective approaches to control the growing burden of NCDs is to reduce related modifiable risk factors. Objective: This study aims to propose a composite health score called Health Index, inspired by the 6 pillars of lifestyle medicine, which acts as a measure of health and can show how health changes over time at an individual and national level. Methods: Health Index is a series of questionnaires that captures users’ health status on several domains of health and, upon completion, the users are categorized as either healthy, at risk, or in poor health. Users will also be able to view health advice based on their answers to the questionnaires. Results: The field testing results show Health Index as a promising population health management tool. 13.8% (166/1200) of the targeted users completed Health Index within 1 month, with 85% (1019/1200) of them in the “At Risk” category. We also identified diet as the most prominent health issue. Conclusions: In conclusion, the Health Index potentially enables early detection and management of NCD risk factors to mitigate the high cost of advanced disease and complications. In the future, we aim to retrospectively and prospectively validate the Health Index through several statistical analyses.
- 26 January 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10 (1) , e74101
Open AccessAn Innovative Population Health Tool for Overall Health Status Assessment: Prospective Observational Study
Background: The World Health Organization reported that noncommunicable diseases (NCDs) contribute to around 74% of deaths worldwide. A similar phenomenon can also be observed in Brunei Darussalam. One of the most cost-effective approaches to control the growing burden of NCDs is to reduce related modifiable risk factors. Objective: This study aims to propose a composite health score called Health Index, inspired by the 6 pillars of lifestyle medicine, which acts as a measure of health and can show how health changes over time at an individual and national level. Methods: Health Index is a series of questionnaires that captures users’ health status on several domains of health and, upon completion, the users are categorized as either healthy, at risk, or in poor health. Users will also be able to view health advice based on their answers to the questionnaires. Results: The field testing results show Health Index as a promising population health management tool. 13.8% (166/1200) of the targeted users completed Health Index within 1 month, with 85% (1019/1200) of them in the “At Risk” category. We also identified diet as the most prominent health issue. Conclusions: In conclusion, the Health Index potentially enables early detection and management of NCD risk factors to mitigate the high cost of advanced disease and complications. In the future, we aim to retrospectively and prospectively validate the Health Index through several statistical analyses.
- Open Access
- 7 November 2022
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 30 (2) , 273-281
Using similar patients to predict complication in patients with diabetes, hypertension, and lipid disorder: a domain knowledge-infused convolutional neural network approach
Objective: This study aims to develop a convolutional neural network-based learning framework called domain knowledge-infused convolutional neural network (DK-CNN) for retrieving clinically similar patient and to personalize the prediction of macrovascular complication using the retrieved patients. Materials and Methods: We use the electronic health records of 169 434 patients with diabetes, hypertension, and/or lipid disorder. Patients are partitioned into 7 subcohorts based on their comorbidities. DK-CNN integrates both domain knowledge and disease trajectory of patients over multiple visits to retrieve similar patients. We use normalized discounted cumulative gain (nDCG) and macrovascular complication prediction performance to evaluate the effectiveness of DK-CNN compared to state-of-the-art models. Ablation studies are conducted to compare DK-CNN with reduced models that do not use domain knowledge as well as models that do not consider short-term, medium-term, and long-term trajectory over multiple visits. Results: Key findings from this study are: (1) DK-CNN is able to retrieve clinically similar patients and achieves the highest nDCG values in all 7 subcohorts; (2) DK-CNN outperforms other state-of-the-art approaches in terms of complication prediction performance in all 7 subcohorts; and (3) the ablation studies show that the full model achieves the highest nDCG compared with other 2 reduced models. Discussion and Conclusions: DK-CNN is a deep learning-based approach which incorporates domain knowledge and patient trajectory data to retrieve clinically similar patients. It can be used to assist physicians who may refer to the outcomes and past treatments of similar patients as a guide for choosing an effective treatment for patients.
- 7 November 2022
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 30 (2) , 273-281
Open AccessUsing similar patients to predict complication in patients with diabetes, hypertension, and lipid disorder: a domain knowledge-infused convolutional neural network approach
Objective: This study aims to develop a convolutional neural network-based learning framework called domain knowledge-infused convolutional neural network (DK-CNN) for retrieving clinically similar patient and to personalize the prediction of macrovascular complication using the retrieved patients. Materials and Methods: We use the electronic health records of 169 434 patients with diabetes, hypertension, and/or lipid disorder. Patients are partitioned into 7 subcohorts based on their comorbidities. DK-CNN integrates both domain knowledge and disease trajectory of patients over multiple visits to retrieve similar patients. We use normalized discounted cumulative gain (nDCG) and macrovascular complication prediction performance to evaluate the effectiveness of DK-CNN compared to state-of-the-art models. Ablation studies are conducted to compare DK-CNN with reduced models that do not use domain knowledge as well as models that do not consider short-term, medium-term, and long-term trajectory over multiple visits. Results: Key findings from this study are: (1) DK-CNN is able to retrieve clinically similar patients and achieves the highest nDCG values in all 7 subcohorts; (2) DK-CNN outperforms other state-of-the-art approaches in terms of complication prediction performance in all 7 subcohorts; and (3) the ablation studies show that the full model achieves the highest nDCG compared with other 2 reduced models. Discussion and Conclusions: DK-CNN is a deep learning-based approach which incorporates domain knowledge and patient trajectory data to retrieve clinically similar patients. It can be used to assist physicians who may refer to the outcomes and past treatments of similar patients as a guide for choosing an effective treatment for patients.
- Open Access
- 12 August 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (8) , 787
Progression-Free Survival Prediction in Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy: Machine Learning vs. Traditional Statistics
Background: The Cox proportional hazards (CPH) model is the most commonly used statistical method for nasopharyngeal carcinoma (NPC) prognostication. Recently, machine learning (ML) models are increasingly adopted for this purpose. However, only a few studies have compared the performances between CPH and ML models. This study aimed at comparing CPH with two state-of-the-art ML algorithms, namely, conditional survival forest (CSF) and DeepSurv for disease progression prediction in NPC. Methods: From January 2010 to March 2013, 412 eligible NPC patients were reviewed. The entire dataset was split into training cohort and testing cohort in a ratio of 90%:10%. Ten features from patient-related, disease-related, and treatment-related data were used to train the models for progression-free survival (PFS) prediction. The model performance was compared using the concordance index (c-index), Brier score, and log-rank test based on the risk stratification results. Results: DeepSurv (c-index = 0.68, Brier score = 0.13, log-rank test p = 0.02) achieved the best performance compared to CSF (c-index = 0.63, Brier score = 0.14, log-rank test p = 0.38) and CPH (c-index = 0.57, Brier score = 0.15, log-rank test p = 0.81). Conclusions: Both CSF and DeepSurv outperformed CPH in our relatively small dataset. ML-based survival prediction may guide physicians in choosing the most suitable treatment strategy for NPC patients.
- 12 August 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (8) , 787
Open AccessProgression-Free Survival Prediction in Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy: Machine Learning vs. Traditional Statistics
Background: The Cox proportional hazards (CPH) model is the most commonly used statistical method for nasopharyngeal carcinoma (NPC) prognostication. Recently, machine learning (ML) models are increasingly adopted for this purpose. However, only a few studies have compared the performances between CPH and ML models. This study aimed at comparing CPH with two state-of-the-art ML algorithms, namely, conditional survival forest (CSF) and DeepSurv for disease progression prediction in NPC. Methods: From January 2010 to March 2013, 412 eligible NPC patients were reviewed. The entire dataset was split into training cohort and testing cohort in a ratio of 90%:10%. Ten features from patient-related, disease-related, and treatment-related data were used to train the models for progression-free survival (PFS) prediction. The model performance was compared using the concordance index (c-index), Brier score, and log-rank test based on the risk stratification results. Results: DeepSurv (c-index = 0.68, Brier score = 0.13, log-rank test p = 0.02) achieved the best performance compared to CSF (c-index = 0.63, Brier score = 0.14, log-rank test p = 0.38) and CPH (c-index = 0.57, Brier score = 0.15, log-rank test p = 0.81). Conclusions: Both CSF and DeepSurv outperformed CPH in our relatively small dataset. ML-based survival prediction may guide physicians in choosing the most suitable treatment strategy for NPC patients.
- Open Access
- 22 July 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (8) , 699
Using Domain Knowledge and Data-Driven Insights for Patient Similarity Analytics
Patient similarity analytics has emerged as an essential tool to identify cohorts of patients who have similar clinical characteristics to some specific patient of interest. In this study, we propose a patient similarity measure called D3K that incorporates domain knowledge and data-driven insights. Using the electronic health records (EHRs) of 169,434 patients with either diabetes, hypertension or dyslipidaemia (DHL), we construct patient feature vectors containing demographics, vital signs, laboratory test results, and prescribed medications. We discretize the variables of interest into various bins based on domain knowledge and make the patient similarity computation to be aligned with clinical guidelines. Key findings from this study are: (1) D3K outperforms baseline approaches in all seven sub-cohorts; (2) our domain knowledge-based binning strategy outperformed the traditional percentile-based binning in all seven sub-cohorts; (3) there is substantial agreement between D3K and physicians (κ = 0.746), indicating that D3K can be applied to facilitate shared decision making. This is the first study to use patient similarity analytics on a cardiometabolic syndrome-related dataset sourced from medical institutions in Singapore. We consider patient similarity among patient cohorts with the same medical conditions to develop localized models for personalized decision support to improve the outcomes of a target patient.
- 22 July 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (8) , 699
Open AccessUsing Domain Knowledge and Data-Driven Insights for Patient Similarity Analytics
Patient similarity analytics has emerged as an essential tool to identify cohorts of patients who have similar clinical characteristics to some specific patient of interest. In this study, we propose a patient similarity measure called D3K that incorporates domain knowledge and data-driven insights. Using the electronic health records (EHRs) of 169,434 patients with either diabetes, hypertension or dyslipidaemia (DHL), we construct patient feature vectors containing demographics, vital signs, laboratory test results, and prescribed medications. We discretize the variables of interest into various bins based on domain knowledge and make the patient similarity computation to be aligned with clinical guidelines. Key findings from this study are: (1) D3K outperforms baseline approaches in all seven sub-cohorts; (2) our domain knowledge-based binning strategy outperformed the traditional percentile-based binning in all seven sub-cohorts; (3) there is substantial agreement between D3K and physicians (κ = 0.746), indicating that D3K can be applied to facilitate shared decision making. This is the first study to use patient similarity analytics on a cardiometabolic syndrome-related dataset sourced from medical institutions in Singapore. We consider patient similarity among patient cohorts with the same medical conditions to develop localized models for personalized decision support to improve the outcomes of a target patient.
- Open Access
- 1 July 2021
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 21 (1) , 1-12
Patient similarity analytics for explainable clinical risk prediction
Background: Clinical risk prediction models (CRPMs) use patient characteristics to estimate the probability of having or developing a particular disease and/or outcome. While CRPMs are gaining in popularity, they have yet to be widely adopted in clinical practice. The lack of explainability and interpretability has limited their utility. Explainability is the extent of which a model’s prediction process can be described. Interpretability is the degree to which a user can understand the predictions made by a model.Methods: The study aimed to demonstrate utility of patient similarity analytics in developing an explainable and interpretable CRPM. Data was extracted from the electronic medical records of patients with type-2 diabetes mellitus, hypertension and dyslipidaemia in a Singapore public primary care clinic. We used modified K-nearest neighbour which incorporated expert input, to develop a patient similarity model on this real-world training dataset (n = 7,041) and validated it on a testing dataset (n = 3,018). The results were compared using logistic regression, random forest (RF) and support vector machine (SVM) models from the same dataset. The patient similarity model was then implemented in a prototype system to demonstrate the identification, explainability and interpretability of similar patients and the prediction process.Results: The patient similarity model (AUROC = 0.718) was comparable to the logistic regression (AUROC = 0.695), RF (AUROC = 0.764) and SVM models (AUROC = 0.766). We packaged the patient similarity model in a prototype web application. A proof of concept demonstrated how the application provided both quantitative and qualitative information, in the form of patient narratives. This information was used to better inform and influence clinical decision-making, such as getting a patient to agree to start insulin therapy.Conclusions: Patient similarity analytics is a feasible approach to develop an explainable and interpretable CRPM. While the approach is generalizable, it can be used to develop locally relevant information, based on the database it searches. Ultimately, such an approach can generate a more informative CRPMs which can be deployed as part of clinical decision support tools to better facilitate shared decision-making in clinical practice.
- 1 July 2021
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 21 (1) , 1-12
Open AccessPatient similarity analytics for explainable clinical risk prediction
Background: Clinical risk prediction models (CRPMs) use patient characteristics to estimate the probability of having or developing a particular disease and/or outcome. While CRPMs are gaining in popularity, they have yet to be widely adopted in clinical practice. The lack of explainability and interpretability has limited their utility. Explainability is the extent of which a model’s prediction process can be described. Interpretability is the degree to which a user can understand the predictions made by a model.Methods: The study aimed to demonstrate utility of patient similarity analytics in developing an explainable and interpretable CRPM. Data was extracted from the electronic medical records of patients with type-2 diabetes mellitus, hypertension and dyslipidaemia in a Singapore public primary care clinic. We used modified K-nearest neighbour which incorporated expert input, to develop a patient similarity model on this real-world training dataset (n = 7,041) and validated it on a testing dataset (n = 3,018). The results were compared using logistic regression, random forest (RF) and support vector machine (SVM) models from the same dataset. The patient similarity model was then implemented in a prototype system to demonstrate the identification, explainability and interpretability of similar patients and the prediction process.Results: The patient similarity model (AUROC = 0.718) was comparable to the logistic regression (AUROC = 0.695), RF (AUROC = 0.764) and SVM models (AUROC = 0.766). We packaged the patient similarity model in a prototype web application. A proof of concept demonstrated how the application provided both quantitative and qualitative information, in the form of patient narratives. This information was used to better inform and influence clinical decision-making, such as getting a patient to agree to start insulin therapy.Conclusions: Patient similarity analytics is a feasible approach to develop an explainable and interpretable CRPM. While the approach is generalizable, it can be used to develop locally relevant information, based on the database it searches. Ultimately, such an approach can generate a more informative CRPMs which can be deployed as part of clinical decision support tools to better facilitate shared decision-making in clinical practice.
- Open Access
- 18 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma
This study aimed to develop prognosis signatures through a radiomics analysis for patients with nasopharyngeal carcinoma (NPC) by their pretreatment diagnosis magnetic resonance imaging (MRI). A total of 208 radiomics features were extracted for each patient from a database of 303 patients. The patients were split into the training and validation cohorts according to their pretreatment diagnosis date. The radiomics feature analysis consisted of cluster analysis and prognosis model analysis for disease free-survival (DFS), overall survival (OS), distant metastasis-free survival (DMFS) and locoregional recurrence-free survival (LRFS). Additionally, two prognosis models using clinical features only and combined radiomics and clinical features were generated to estimate the incremental prognostic value of radiomics features. Patients were clustered by non-negative matrix factorization (NMF) into two groups. It showed high correspondence with patients’ T stage (p < 0.00001) and overall stage information (p < 0.00001) by chi-squared tests. There were significant differences in DFS (p = 0.0052), OS (p = 0.033), and LRFS (p = 0.037) between the two clustered groups but not in DMFS (p = 0.11) by log-rank tests. Radiomics nomograms that incorporated radiomics and clinical features could estimate DFS with the C-index of 0.751 [0.639, 0.863] and OS with the C-index of 0.845 [0.752, 0.939] in the validation cohort. The nomograms improved the prediction accuracy with the C-index value of 0.029 for DFS and 0.107 for OS compared with clinical features only. The DFS and OS radiomics nomograms developed in our study demonstrated the excellent prognostic estimation for NPC patients with a noninvasive way of MRI. The combination of clinical and radiomics features can provide more information for precise treatment decision.
- 18 July 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Open AccessMRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma
This study aimed to develop prognosis signatures through a radiomics analysis for patients with nasopharyngeal carcinoma (NPC) by their pretreatment diagnosis magnetic resonance imaging (MRI). A total of 208 radiomics features were extracted for each patient from a database of 303 patients. The patients were split into the training and validation cohorts according to their pretreatment diagnosis date. The radiomics feature analysis consisted of cluster analysis and prognosis model analysis for disease free-survival (DFS), overall survival (OS), distant metastasis-free survival (DMFS) and locoregional recurrence-free survival (LRFS). Additionally, two prognosis models using clinical features only and combined radiomics and clinical features were generated to estimate the incremental prognostic value of radiomics features. Patients were clustered by non-negative matrix factorization (NMF) into two groups. It showed high correspondence with patients’ T stage (p < 0.00001) and overall stage information (p < 0.00001) by chi-squared tests. There were significant differences in DFS (p = 0.0052), OS (p = 0.033), and LRFS (p = 0.037) between the two clustered groups but not in DMFS (p = 0.11) by log-rank tests. Radiomics nomograms that incorporated radiomics and clinical features could estimate DFS with the C-index of 0.751 [0.639, 0.863] and OS with the C-index of 0.845 [0.752, 0.939] in the validation cohort. The nomograms improved the prediction accuracy with the C-index value of 0.029 for DFS and 0.107 for OS compared with clinical features only. The DFS and OS radiomics nomograms developed in our study demonstrated the excellent prognostic estimation for NPC patients with a noninvasive way of MRI. The combination of clinical and radiomics features can provide more information for precise treatment decision.
- Open Access
- 13 March 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (3) , e0213626
Convolutional neural network for cell classification using microscope images of intracellular actin networks
Automated cell classification is an important yet a challenging computer vision task with significant benefits to biomedicine. In recent years, there have been several studies attempted to build an artificial intelligence-based cell classifier using label-free cellular images obtained from an optical microscope. Although these studies showed promising results, such classifiers were not able to reflect the biological diversity of different types of cell. While in terms of malignant cell, it is well-known that intracellular actin filaments are altered substantially. This is thought to be closely related to the abnormal growth features of tumor cells, their ability to invade surrounding tissues and also to metastasize. Therefore, being able to classify different types of cell based on their biological behaviors using automated technique is more advantageous. This article reveals the difference in the actin cytoskeleton structures between breast normal and cancer cells, which may provide new information regarding malignant changes and be used as additional diagnostic marker. Since the features cannot be well detected by human eyes, we proposed the application of convolutional neural network (CNN) in cell classification based on actin-labeled fluorescence microscopy images. The CNN was evaluated on a large number of actin-labeled fluorescence microscopy images of one human normal breast epithelial cell line and two types of human breast cancer cell line with different levels of aggressiveness. The study revealed that the CNN performed better in the cell classification task compared to a human expert.
- 13 March 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (3) , e0213626
Open AccessConvolutional neural network for cell classification using microscope images of intracellular actin networks
Automated cell classification is an important yet a challenging computer vision task with significant benefits to biomedicine. In recent years, there have been several studies attempted to build an artificial intelligence-based cell classifier using label-free cellular images obtained from an optical microscope. Although these studies showed promising results, such classifiers were not able to reflect the biological diversity of different types of cell. While in terms of malignant cell, it is well-known that intracellular actin filaments are altered substantially. This is thought to be closely related to the abnormal growth features of tumor cells, their ability to invade surrounding tissues and also to metastasize. Therefore, being able to classify different types of cell based on their biological behaviors using automated technique is more advantageous. This article reveals the difference in the actin cytoskeleton structures between breast normal and cancer cells, which may provide new information regarding malignant changes and be used as additional diagnostic marker. Since the features cannot be well detected by human eyes, we proposed the application of convolutional neural network (CNN) in cell classification based on actin-labeled fluorescence microscopy images. The CNN was evaluated on a large number of actin-labeled fluorescence microscopy images of one human normal breast epithelial cell line and two types of human breast cancer cell line with different levels of aggressiveness. The study revealed that the CNN performed better in the cell classification task compared to a human expert.
- Open Access
- 8 February 2019
- Published by Springer Nature in Radiation Oncology
- Vol. 14 (1) , 1-11
Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
In patients with T4 nasopharyngeal carcinoma (NPC), death may occur prior to the occurrence of temporal lobe injury (TLI). Because such competing risk death precludes the occurrence of TLI and thus the competing risk analysis should be applied to TLI research. The aim was to investigate the incidence and predictive factors of TLI after intensity-modulated radiotherapy (IMRT) among T4 NPC patients. From March 2008 to December 2014, T4 NPC patients treated with full-course radical IMRT at our center were reviewed retrospectively. A nested case-control study was designed for this cohort of patients. The cases were patients with TLI diagnosed by MRI during the follow-up period, and the controls were patients without TLI after IMRT matched 1:1 to each case by gender, age at diagnosis, intercranial involvement, and follow-up time. The end point was time to TLI or death without prior TLI. We analyzed the cumulative incidence function (CIF) and performed a competing risk regression model to identify the predictors of TLI. With a median follow-up of 40.1 months, 63 patients (63/506, 12.5%) developed TLI as diagnosed by MRI, and 136 deaths occurred during the period. The cumulative incidence of TLI at 5 years was 13.2%, while 26.7% died without prior TLI. The univariate analysis showed that all selected dosimetric parameters were associated with the occurrence of TLI. On multivariate analysis, D1cc and V20 remained statistically significant. Based on the area-under-the-curve (AUC) values, D1cc was considered the most predictive. The patients with D1cc > 71.14 Gy had a 7.920-fold increased risk of TLI compared with those with D1cc ≤71.14 Gy (P < 0.05). Similarly, V20 > 42.22 cc was found to result in a statistically significant higher risk of TLI (subdistribution hazard ratio [sHR] =3.123, P < 0.05). TL D1cc and V20 were predictive of TLI after IMRT for T4 NPC. They should be considered as first and second priorities of dose constraints of the TL. D1cc ≤71.14 Gy and V20 ≤ 42.22 cc could be useful dose-volume constraints for reducing the occurrence of TLI during IMRT treatment planning without obviously compromising the tumor coverage.
- 8 February 2019
- Published by Springer Nature in Radiation Oncology
- Vol. 14 (1) , 1-11
Open AccessDosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
In patients with T4 nasopharyngeal carcinoma (NPC), death may occur prior to the occurrence of temporal lobe injury (TLI). Because such competing risk death precludes the occurrence of TLI and thus the competing risk analysis should be applied to TLI research. The aim was to investigate the incidence and predictive factors of TLI after intensity-modulated radiotherapy (IMRT) among T4 NPC patients. From March 2008 to December 2014, T4 NPC patients treated with full-course radical IMRT at our center were reviewed retrospectively. A nested case-control study was designed for this cohort of patients. The cases were patients with TLI diagnosed by MRI during the follow-up period, and the controls were patients without TLI after IMRT matched 1:1 to each case by gender, age at diagnosis, intercranial involvement, and follow-up time. The end point was time to TLI or death without prior TLI. We analyzed the cumulative incidence function (CIF) and performed a competing risk regression model to identify the predictors of TLI. With a median follow-up of 40.1 months, 63 patients (63/506, 12.5%) developed TLI as diagnosed by MRI, and 136 deaths occurred during the period. The cumulative incidence of TLI at 5 years was 13.2%, while 26.7% died without prior TLI. The univariate analysis showed that all selected dosimetric parameters were associated with the occurrence of TLI. On multivariate analysis, D1cc and V20 remained statistically significant. Based on the area-under-the-curve (AUC) values, D1cc was considered the most predictive. The patients with D1cc > 71.14 Gy had a 7.920-fold increased risk of TLI compared with those with D1cc ≤71.14 Gy (P < 0.05). Similarly, V20 > 42.22 cc was found to result in a statistically significant higher risk of TLI (subdistribution hazard ratio [sHR] =3.123, P < 0.05). TL D1cc and V20 were predictive of TLI after IMRT for T4 NPC. They should be considered as first and second priorities of dose constraints of the TL. D1cc ≤71.14 Gy and V20 ≤ 42.22 cc could be useful dose-volume constraints for reducing the occurrence of TLI during IMRT treatment planning without obviously compromising the tumor coverage.
- Open Access
- 1 August 2018
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 10, 2785-2797
Prognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma: a propensity score matching study
Purpose: The aim of this article is to investigate the significance of pretreatment prognostic nutritional index (PNI), systemic immune-inflammation index (SII), and their combination in nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT). Materials and methods: A total of 585 patients were included. PNI and SII were calculated within 2 weeks prior to treatment. The optimal cutoff points were determined based on receiver operating characteristics curve analysis. The correlation between variables was analyzed. Kaplan–Meier method and Cox proportional hazards model were performed to evaluate the impact of both indices on overall survival (OS), progression-free survival (PFS) and distant metastasis-free survival (DMFS). Further propensity score matching (PSM) was carried out to minimize the effects of confounders. Results: The optimal cutoff point of 53.0 for PNI and 527.20 for SII were selected. Pearson correlation coefficient showed an inverse correlation between PNI and SII (r = –0.232, P < 0.001). Multivariate analysis demonstrated that pretreatment PNI was an independent prognostic factor for OS (P = 0.047) and DMFS (P = 0.002) while pretreatment SII was an independent prognostic factor for OS (P = 0.003), PFS (P = 0.002), and DMFS (P = 0.002). After PSM, both parameters remained as independent prognosticators of survival. Additional prognostic value was observed in the combined use of PNI and SII. Conclusion: Pretreatment PNI and SII are promising indicators of survival in NPC patients undergoing IMRT. They can be utilized to refine current TNM staging system in predicting prognosis and developing an individualized treatment in these patients.
- 1 August 2018
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 10, 2785-2797
Open AccessPrognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma: a propensity score matching study
Purpose: The aim of this article is to investigate the significance of pretreatment prognostic nutritional index (PNI), systemic immune-inflammation index (SII), and their combination in nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT). Materials and methods: A total of 585 patients were included. PNI and SII were calculated within 2 weeks prior to treatment. The optimal cutoff points were determined based on receiver operating characteristics curve analysis. The correlation between variables was analyzed. Kaplan–Meier method and Cox proportional hazards model were performed to evaluate the impact of both indices on overall survival (OS), progression-free survival (PFS) and distant metastasis-free survival (DMFS). Further propensity score matching (PSM) was carried out to minimize the effects of confounders. Results: The optimal cutoff point of 53.0 for PNI and 527.20 for SII were selected. Pearson correlation coefficient showed an inverse correlation between PNI and SII (r = –0.232, P < 0.001). Multivariate analysis demonstrated that pretreatment PNI was an independent prognostic factor for OS (P = 0.047) and DMFS (P = 0.002) while pretreatment SII was an independent prognostic factor for OS (P = 0.003), PFS (P = 0.002), and DMFS (P = 0.002). After PSM, both parameters remained as independent prognosticators of survival. Additional prognostic value was observed in the combined use of PNI and SII. Conclusion: Pretreatment PNI and SII are promising indicators of survival in NPC patients undergoing IMRT. They can be utilized to refine current TNM staging system in predicting prognosis and developing an individualized treatment in these patients.